These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9772411)

  • 1. Nasopharyngeal carcinoma research in Hong Kong in the past decade.
    Sham JS; Wei W; Ng MH; Nicholls J; Choy D
    Chin Med J (Engl); 1997 Nov; 110(11):826-31. PubMed ID: 9772411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong.
    Lo S; Ho WK; Wei WI
    Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Hui EP; Leung SF; Au JS; Zee B; Tung S; Chua D; Sze WM; Law CK; Leung TW; Chan AT
    Cancer; 2004 Jul; 101(2):300-6. PubMed ID: 15241827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.
    Ng MH; Chan KH; Ng SP; Zong YS
    Ai Zheng; 2006 Feb; 25(2):250-6. PubMed ID: 16480597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo real-time diagnosis of nasopharyngeal carcinoma in situ by contact rhinoscopy.
    Wai Pak M; To KF; Lee JC; Liang EY; van Hasselt CA
    Head Neck; 2005 Nov; 27(11):1008-13. PubMed ID: 16134185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
    Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models.
    Chen HH; Prevost TC; Duffy SW
    Br J Cancer; 1999 Apr; 79(11-12):1894-900. PubMed ID: 10206310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
    Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
    J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
    Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
    Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
    Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China.
    Ji KM; Li CL; Meng G; Han AD; Wu XL
    Arch Virol; 2008; 153(10):1949-53. PubMed ID: 18807115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal carcinoma: methods of presentation.
    Skinner DW; Van Hasselt CA
    Ear Nose Throat J; 1990 Apr; 69(4):237-40. PubMed ID: 2351084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in nasopharyngeal carcinoma.
    Guigay J
    Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the study of the pathogenesis of nasopharyngeal carcinoma (NPC).
    Yao K
    Chin Med J (Engl); 1995 Aug; 108(8):566-8. PubMed ID: 7587483
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus in nasopharyngeal carcinoma in Indian patients.
    Rathaur RG; Chitale AR; Banerjee K
    Indian J Cancer; 1999; 36(2-4):80-90. PubMed ID: 10921211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China.
    Jia WH; Feng BJ; Xu ZL; Zhang XS; Huang P; Huang LX; Yu XJ; Feng QS; Yao MH; Shugart YY; Zeng YX
    Cancer; 2004 Jul; 101(2):363-9. PubMed ID: 15241835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of nasopharyngeal carcinoma in Malaysia and Hong Kong.
    Yu MC; Ho JH; Henderson BE; Armstrong RW
    Natl Cancer Inst Monogr; 1985 Dec; 69():203-7. PubMed ID: 3834333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].
    Zhang Y; Gao HY; Feng HX; Deng L; Huang MY; Hu B; Cheng G; Wu QL; Cui NJ; Shao JY
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):982-6. PubMed ID: 15312530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBER1 in situ hybridization as an adjuvant for diagnosis of recurrent nasopharyngeal carcinoma.
    Hsiao JR; Jin YT; Tsai ST
    Anticancer Res; 1998; 18(6B):4585-9. PubMed ID: 9891523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.